GSK Joint Venture Files New Drug Application for HIV Treatment

Published December 20, 2012

GSK joint venture files new drug application for HIV treatment

Filed under: drug treatment news

Research Triangle Park, N.C. — A new AIDS drug may soon be on its way to market. ViiV Healthcare, a joint venture of GlaxoSmithKline, Pfizer and Shionogi, filed for regulatory approval of its proposed treatment for HIV on Monday in the U.S., Canada …
Read more on WRAL Tech Wire

Brooke Mueller checks back into rehab for Adderall addiction, marking her 19th …

Filed under: drug treatment news

The troubled ex-wife of Charlie Sheen checked back into rehab Monday night to seek treatment for an addiction to Adderall, a psycho-stimulant drug commonly used for attention deficit disorder (ADD), according to TMZ. This would be the whopping 19th …
Read more on New York Daily News

Novel Drug Therapy Targets Aggressive Form of Non-Hodgkin's Lymphoma

Filed under: drug treatment news

Dec. 10, 2012 — Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell — DLBCL …
Read more on Science Daily (press release)